HR 1922 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Ensuring Access to Essential Drugs Act
To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
Summary
This bill amends the Medicare Part D prescription drug program to create an exemption from the manufacturer discount requirement for certain orally administered drugs. The exemption applies to drugs that received FDA approval as a new drug application and have been granted a narrow exception by the Centers for Medicare & Medicaid Services allowing reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program. The bill effectively excludes these specific drugs from Part D's manufacturer discount program.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
Actions (2)
- Mar 6, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Mar 6, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 6, 2025
Mr. Garbarino (for himself, Mrs. Harshbarger, and Mr. Suozzi) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Ensuring Access to Essential Drugs Act”.
SEC. 2. EXEMPTING CERTAIN DRUGS FROM THE PART D MANUFACTURER DISCOUNT PROGRAM UNDER THE MEDICARE PROGRAM.
Section 1860D-14C(g)(2) of the Social Security Act (42 U.S.C. 1395w-114c(g)(2)) is amended—
(1) in subparagraph (A), by striking “and” at the end;
(2) in subparagraph (B), by striking the period and inserting “; and”; and
(3) by adding at the end the following new subparagraph:
“(C) does not include an orally administered drug—
“(i) for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and
“(ii) that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services.”. <all>
Comments